Author

Rahul Khemchandani

Observed name: Khemchandani, Rahul

Institutions: Novartis (India), National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

Observed institutions: Novartis (India), National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

ORCID: 0000-0002-3474-7773

Observed ORCID: 0000-0002-3474-7773

OpenAlex ID: A5001106832

Design, development and characterization of the Apremilast and Indomethacin coamorphous system

2023 · Ekta Pardhi, Devendra Singh Tomar, et al. · Journal of Molecular Structure · 28

Enhancing solubility, bioavailability and anti-cancer efficacy of aprepitant through a naringin-based co-amorphous system

2025 · Ekta Pardhi, Devendra Singh Tomar, et al. · Journal of Molecular Liquids · 27

In silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: Integrating DFT, molecular docking, MD simulations, and ADME analysis

2025 · H M Chandra Mouli, Dharipally Harini, et al. · Journal of Molecular Structure · 21

Multi-method coamorphous systems of lumefantrine with alpha ketoglutaric acid: Comprehensive characterization, biological evaluation and stability analysis

2024 · Rahul Khemchandani, Ekta Pardhi, et al. · International Journal of Pharmaceutics · 19

Enhanced bioavailability and therapeutic efficacy of Ibrutinib and naringenin-loaded self-nanoemulsifying drug delivery system

2025 · Sitaram Jati, Ekta Pardhi, et al. · Journal of Drug Delivery Science and Technology · 14

Monophasic coamorphous sulpiride: a leap in physicochemical attributes and dual inhibition of GlyT1 and P-glycoprotein, supported by experimental and computational insights

2024 · Ekta Pardhi, Devendra Singh Tomar, et al. · Journal of Biomolecular Structure and Dynamics · 14

Structural characterization and in silico toxicity prediction of degradation impurities of roxadustat

2023 · Rupali Mahajan, Sanjeev Kumar, et al. · Journal of Pharmaceutical and Biomedical Analysis · 14

Structural characterization of novel hydrolytic and oxidative degradation products of acalabrutinib by LC-Q-TOF-MS, H/D exchange and NMR

2022 · Bhoopendra Singh Kushwah, Hara Prasad Padhy, et al. · Journal of Pharmaceutical and Biomedical Analysis · 12

Forced degradation study of baricitinib and structural characterization of its degradation impurities by high‐resolution mass spectrometry and nuclear magnetic resonance spectroscopy

2023 · Sowmya Chaganti, Vivek Dhiman, et al. · Rapid Communications in Mass Spectrometry · 11

PEGylated liposomes co-encapsulating darolutamide and hesperetin for enhanced prostate cancer therapy: 2D, 3D PC3 models and in-vivo evaluation

2025 · Ruchita Patil, Ekta Pardhi, et al. · Biomaterials Advances · 10

Niosomal gel improves dermal delivery of nimbolide: a promising approach for treatment of psoriasis

2024 · Sowjanya Thatikonda, Sai Prabha Rasoju, et al. · Nanomedicine · 9

Strategic Nanosuspension of Darolutamide for Enhanced Dissolution, Bioavailability, and Potentiated Prostate Cancer Treatment: Insights from Multiscale Computational Modeling

2025 · Ekta Pardhi, Rahul Khemchandani, et al. · ACS Applied Bio Materials · 7

Separation and characterization of hydrolytic degradation product of deucravacitinib by validated high‐performance liquid chromatography method and liquid chromatography‐mass spectrometry

2024 · Vijaya Madhyanapu Golla, Rahul Khemchandani, et al. · Separation Science Plus · 7

Integrated experimental, computational and machine learning approaches for the development of Apremilast-Aceclofenac coamorphous systems

2025 · Rahul Khemchandani, Ekta Pardhi, et al. · International Journal of Pharmaceutics · 5

Understanding the degradation behavior of masitinib by Stress testing, UHPLC, HRMS, NMR, APCI-MS, DFT and prediction of toxicity using in silico tools

2025 · Vivek Dhiman, Rahul Khemchandani, et al. · Journal of Pharmaceutical Sciences · 5

Identification and characterization of forced degradation products of lumateperone tosylate by LC-HRMS, GC-MS, NMR, and in silico toxicity prediction

2025 · Nehal Bhatt, Devendra Sonaje, et al. · Journal of Pharmaceutical and Biomedical Analysis Open · 5

Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance

2025 · Nagesh A. Bhale, Avvaru Subha Jahnavi, et al. · Molecular Pharmaceutics · 4

Covalent organic frameworks: spotlight on applications in the pharmaceutical arena

2024 · Pushpa Pilli, Hema Sree Kommalapati, et al. · Bioanalysis · 4

PDF

Identification and Structural Characterization of Degradation Products of Tivozanib Using LC‐Q‐TOF‐MS/MS and NMR: An In Silico Approach for Degradation and Toxicity Prediction

2025 · Nadeem Shaikh, Sowmya Chaganti, et al. · Rapid Communications in Mass Spectrometry · 3

Engineered aprepitant-chitosan coated bovine serum albumin nanoparticles: A promising approach for treatment of breast cancer therapy

2025 · Kashish Joshi, Ekta Pardhi, et al. · International Journal of Biological Macromolecules · 3

An Unusual, Methylated Impurity in Diethyl Sulphate: Identification, Structure Elucidation, and Linkage with N‐Methyl Impurity of An Active Pharmaceutical Ingredient

2025 · Nagesh A. Bhale, Ganesh Birajdar, et al. · ChemistrySelect · 3

Characterization of forced degradation products of tyrosine kinase inhibitor apatinib mesylate by LC-MS/MS and NMR with in silico toxicity assessment

2026 · Nadeem Shaikh, Rahul Khemchandani, et al. · Journal of Pharmaceutical and Biomedical Analysis · 2

Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC‐MS/MS, Docking, MD Simulations, and In Vitro Evaluation

2026 · Dharipally Harini, H. M. Chandra Mouli, et al. · Chemistry & Biodiversity · 2

Integrative Study on Triclabendazole Stability: Forced Degradation and In Silico Toxicity Prediction of Degradation Products

2025 · Kavita Pimpre, Sowmya Chaganti, et al. · Biomedical Chromatography · 2

PDF

Analytical Quality by Design Enabled Green RP‐HPLC Method Development and Validation for the Simultaneous Quantitation of the Cleaning Residues of Osimertinib, Binimetinib, and Erdafitinib: An Approach to Prevent the Cross‐Contamination in Shared Facilities of Pharmaceutical Manufacturing

2025 · Jainendra Kumar Jain, K. Sujatha, et al. · Separation Science Plus · 2

Works count: 35

Citation count: 237

H-index: 10

I10-index: 10